Hi folks I have the pleasure of being joined by Dr Robert Malone whose work was instrumental in the development of the

MRNA vaccines and upon the COVID outbreak became a slightly controversial figure for having a contrarian opinion about the rollout of said vaccines.

Now I'm understating the case quite a lot there, so I thought Dr Malone, if you'd like to explain to us your background and authority on the subject and what it was about the vaccine rollout to which you objected.

So I'm a physician and a scientist licensed in the state of

Maryland here in the United States trained at UC Davis, UC San Diego,

the Salk Institute in the Laboratories of Molecular Biology and

biology. Northwestern University in Chicago for my MD which is one of the top clinical universities in the United States for medical

and Harvard Medical School and UC Davis for my fellowships. The Harvard Fellowship was in global clinical research, including bioethics and regulatory affairs and biostatistics and basically a brief set of training in epidemiology.

And on top of that I have about 30 years of experience in beginning in their early 1980s spanning the onset of the

AIDS events when I was at UC Davis through the present. I've been a expert, become an expert in vaccine

development, biotechnology, regulatory affairs, clinical research, program management, largely with the government.

And as a contractor or consultant, I've won over $10 billion, that was with a B, U.S. dollars in grants and contracts for my various clients over time. That does not mean that I got 10 billion dollars

but rather as a consultant and employee I have led on the development of

proposals that have been awarded to that level.

I've been repeatedly served as a study section chairperson or a

study section member for the NIH and the Department of Defense in biotechnology, biodefense, and vaccine development in particular,

usually for very large contracts.

So, I'm 10 million to 100 million dollars.

This is my space. I'm one of the few that are adroit and experience both in discovery research,

as well as in what technically we call advanced development,

which is the process that comes after you discover

a candidate product and is necessary to bring it

...